The management and treatment of hypertension was the topic of this presentation by UPMC's Dr. James Johnson. This presentation was part of UPMC’s Update in Internal Medicine 2010: Evidence-Based Approaches to Common Medical Problems.
Educational Objectives:
Following this course, participants will be able to:
- Discuss the importance of treating hypertension in order to prevent its consequences
- Identify the recommended drug treatments, combinations, and sequencing, and some of their results, including the recommended first-line drug for treating hypertension
- Identify the most important predictor for progression of ESRD and death in hypertension
Faculty Disclosure:
Dr. Johston is a stockholder with Merck, Pfizer, and Baxter.
Accreditation Statement:
The
University of Pittsburgh School of Medicine is accredited by the
Accreditation Council for Continuing Medical Education (ACCME) to
provide continuing medical education for physicians. The University of
Pittsburgh School of Medicine designates this educational activity for a
maximum of .5 AMA PRA Category 1 CreditsTM. Each physician
should only claim credit commensurate with the extent of their
participation in the activity. Other health care professionals are
awarded (0.05) continuing education units (CEU) which are equivalent to
0.5 hours.
For
your credit transcript, please access our website 4 weeks
post-completion at http://ccehs.upmc.edu and follow the link to the
Credit Transcript page. If you do not provide the last 5 digits of your
SSN on the next page you will not be able to access a CME credit
transcript. Providing your SSN is voluntary.
Release Date 4/29/2011 | Review Date 4/29/2011 | Expiration Date 4/28/2012
Title: Hypertension
Faculty: James R. Johnston, MD
Target Audience: nephrologists, general practitioners
Educational Objectives:
Following this course, participants will be able to:
* Improve their diagnostic skills for recognizing hypertension
* Outline a basic plan of evaluation in a patient with hypertension
* Explain therapeutic interventions for the treatment of hypertension
Faculty Disclosure:
Dr. Johston is a stockholder with Merck, Pfizer, and Baxter.
Accreditation Statement:
The
University of Pittsburgh School of Medicine is accredited by the
Accreditation Council for Continuing Medical Education (ACCME) to
provide continuing medical education for physicians. The University of
Pittsburgh School of Medicine designates this educational activity for a
maximum of .5 AMA PRA Category 1 CreditsTM. Each physician
should only claim credit commensurate with the extent of their
participation in the activity. Other health care professionals are
awarded (0.05) continuing education units (CEU) which are equivalent to
0.5 hours.
Release Date 4/29/2011 | Review Date 4/29/2011 | Expiration Date 4/28/2012
For
your credit transcript, please access our website 4 weeks
post-completion at http://ccehs.upmc.edu and follow the link to the
Credit Transcript page. If you do not provide the last 5 digits of your
SSN on the next page you will not be able to access a CME credit
transcript. Providing your SSN is voluntary.
Title: Hypertension
Faculty: James R. Johnston, MD
Target Audience: nephrologists, general practitioners
Educational Objectives
Following this course, participants will be able to:
* Improve their diagnostic skills for recognizing hypertension
* Outline a basic plan of evaluation in a patient with hypertension
* Explain therapeutic interventions for the treatment of hypertension
Faculty Disclosure
Dr. Johston is a stockholder with Merck, Pfizer, Amgen, and Baxter.
Accreditation Statement
The
University of Pittsburgh School of Medicine is accredited by the
Accreditation Council for Continuing Medical Education (ACCME)
to
provide continuing medical education for physicians. The University of
Pittsburgh School of Medicine designates this educational
activity
for a maximum of .75 AMA PRA Category 1 CreditsTM. Each physician
should only claim credit commensurate with the extent of
their
participation in the activity. Other health care professionals are
awarded (0.075) continuing education units (CEU) which are
equivalent to 0.75 hours.
Release Date 4/26/2011 | Review Date 4/26/2011 | Expiration Date 4/25/2012
For
your credit transcript, please access our website 4 weeks
post-completion at http://ccehs.upmc.edu and follow the link to the
Credit
Transcript page. If you do not provide the last 5 digits of your SSN on
the next page you will not be able to access a CME
credit transcript. Providing your SSN is voluntary.
Title: Hypertension
Faculty: James R. Johnston, MD
Target Audience: nephrologists, general practitioners
Educational Objectives
Following this course, participants will be able to:
* Improve their diagnostic skills for recognizing hypertension
* Outline a basic plan of evaluation in a patient with hypertension
* Explain therapeutic interventions for the treatment of hypertension
Faculty Disclosure
Dr. Johston is a stockholder with Merck, Pfizer, Amgen, and Baxter.
Accreditation Statement
The
University of Pittsburgh School of Medicine is accredited by the
Accreditation Council for Continuing Medical Education (ACCME)
to
provide continuing medical education for physicians. The University of
Pittsburgh School of Medicine designates this educational
activity
for a maximum of .75 AMA PRA Category 1 CreditsTM. Each physician
should only claim credit commensurate with the extent of
their
participation in the activity. Other health care professionals are
awarded (0.075) continuing education units (CEU) which are
equivalent to 0.75 hours.
Release Date 4/26/2011 | Review Date 4/26/2011 | Expiration Date 4/25/2012
For
your credit transcript, please access our website 4 weeks
post-completion at http://ccehs.upmc.edu and follow the link to the
Credit
Transcript page. If you do not provide the last 5 digits of your SSN on
the next page you will not be able to access a CME
credit transcript. Providing your SSN is voluntary.
